Antiviral Res. 2020 Mar 5;177:104762. doi: 10.1016/j.antiviral.2020.104762. [Epub ahead of print] Of chloroquine and COVID-19.

Touret F1, de Lamballerie X2.
Author information

Abstract

Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Copyright ? 2020 Elsevier B.V. All rights reserved.


KEYWORDS:

2019-nCoV; Antiviral; COVID-19; Chloroquine; SARS-CoV-2

PMID: 32147496 DOI: 10.1016/j.antiviral.2020.104762